118 related articles for article (PubMed ID: 8382584)
21. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
22. Significance of hepatic arterial responsiveness for adequate tissue oxygenation upon portal vein occlusion in cirrhotic livers.
Mücke I; Richter S; Menger MD; Vollmar B
Int J Colorectal Dis; 2000 Nov; 15(5-6):335-41. PubMed ID: 11151440
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
Zhao X; Deng B; Xu XY; Yang SJ; Zhang T; Song YJ; Liu XT; Wang YQ; Cai DY
World J Gastroenterol; 2013 Sep; 19(36):6069-76. PubMed ID: 24106408
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
25. Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis.
Krähenbühl S; Reichen J
J Hepatol; 1993 Aug; 19(1):64-70. PubMed ID: 8301044
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.
Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX
World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459
[TBL] [Abstract][Full Text] [Related]
27. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
[TBL] [Abstract][Full Text] [Related]
28. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
29. Amiloride reduces portal hypertension in rat liver cirrhosis.
Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
[TBL] [Abstract][Full Text] [Related]
30. Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats.
Xuan R; Zhao X; Jian J; Hu D; Qin L; Lv W; Hu C
Microvasc Res; 2019 Sep; 125():103884. PubMed ID: 31176686
[TBL] [Abstract][Full Text] [Related]
31. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
32. Role of hepatic artery in haemodynamics in normal and cirrhotic livers in rats.
Shibayama Y; Nakata K
J Gastroenterol Hepatol; 1991; 6(6):591-4. PubMed ID: 1782375
[TBL] [Abstract][Full Text] [Related]
33. Arterialization of the portal vein improves hepatic microcirculation and tissue oxygenation in experimental cirrhosis.
Yang W; Koti R; Glantzounis G; Davidson BR; Seifalian AM
Br J Surg; 2003 Oct; 90(10):1232-9. PubMed ID: 14515292
[TBL] [Abstract][Full Text] [Related]
34. Portal vein clamping alone confers protection against hepatic ischemia-reperfusion injury via preserving hepatocyte function in cirrhotic rats.
Hu JJ; Li CH; Wang HD; Xu WL; Zhang AQ; Dong JH
J Surg Res; 2015 Mar; 194(1):139-46. PubMed ID: 25481529
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic flow disturbance as detected by in vivo acridine orange staining in endothelin-1-treated and cirrhotic rats.
Masuda Y; Oguma T; Kaneko H
Jpn J Pharmacol; 1998 Aug; 77(4):315-8. PubMed ID: 9749934
[TBL] [Abstract][Full Text] [Related]
36. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
Rockey DC; Chung JJ
Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
[TBL] [Abstract][Full Text] [Related]
37. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
39. Effect of interferon gamma on intrahepatic haemodynamics of the cirrhotic rat liver.
Grossman HJ; White D; Grossman VL; Bhathal PS
J Gastroenterol Hepatol; 1998 Oct; 13(10):1058-60. PubMed ID: 9835324
[TBL] [Abstract][Full Text] [Related]
40. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
